Thomas J. Appio

2018

In 2018, Thomas J. Appio earned a total compensation of $4.4M as President & Co, Head, Bausch + Lomb/International at Valeant Pharmaceuticals International, a 28% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$918,000
Option Awards$389,954
Salary$730,385
Stock Awards$1,365,256
Other$983,007
Total$4,386,602

Appio received $1.4M in stock awards, accounting for 31% of the total pay in 2018.

Appio also received $918K in non-equity incentive plan, $390K in option awards, $730.4K in salary and $983K in other compensation.

Rankings

In 2018, Thomas J. Appio's compensation ranked 2,451st out of 14,244 executives tracked by ExecPay. In other words, Appio earned more than 82.8% of executives.

ClassificationRankingPercentile
All
2,451
out of 14,244
83rd
Division
Manufacturing
903
out of 5,758
84th
Major group
Chemicals And Allied Products
307
out of 2,119
86th
Industry group
Drugs
249
out of 1,808
86th
Industry
Pharmaceutical Preparations
192
out of 1,382
86th

Pay ratio

Thomas J. Appio's Pay$4,386,602
Median Employee's Pay$37,872
Pay Ratio

116

to 1

In 2018, the annual total compensation of Thomas J. Appio was $4,386,602.

The annual total compensation of the median employee at Valeant Pharmaceuticals International was $37,872.

The ratio of Thomas J. Appio's pay to the pay of median employee was therefore 116 to one.

Source: SEC filing on March 18, 2019.

Appio's colleagues

We found four more compensation records of executives who worked with Thomas J. Appio at Valeant Pharmaceuticals International in 2018.

2018

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

2018

Paul Herendeen

Valeant Pharmaceuticals International

Chief Financial Officer

2018

Christina Ackermann

Valeant Pharmaceuticals International

General Counsel

2018

Joseph Gordon

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

News

You may also like